Eu­roAPI’s blue­print for ‘lean­er’ op­er­a­tions in­cludes drop­ping prod­ucts, po­ten­tial lay­offs and sites put on ice

Eu­roAPI is count­ing on 2024 to be its “year of tran­si­tion” as the small mol­e­cule pro­duc­er plans to dis­con­tin­ue API as­sets, po­ten­tial­ly make lay­offs and “moth­ball” or di­vest sites. Its re­struc­tur­ing project, dubbed FO­CUS-27, will be dri­ven by its new­ly ap­point­ed CEO, Lud­wig de Mot.

Nonethe­less, the stock $EAPI.PA of Eu­roAPI — a Sanofi API spin­off — plum­met­ed by as much as 45% on Thurs­day af­ter the com­pa­ny de­tailed its plans on Wednes­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER